ArticleFluids and barriers of the CNS2026
Ventricular volumetry in relation to clinical response and overdrainage after shunt surgery in idiopathic normal-pressure hydrocephalus: a three-year prospective study.
Article in Fluids and barriers of the CNS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIdiopathic normal pressure hydrocephalus (iNPH) is treated with shunt surgery, but long-term monitoring of shunt function and complications remains challenging. Traditional radiological measures such as the Evans index lack sensitivity for detecting subtle longitudinal ventricular changes. Ventricular volumetry may provide a more precise method, but prospective long-term data are scarce.
objectiveTo evaluate ventricular volumetry in relation to clinical outcome, overdrainage, and valve adjustments during a structured three-year follow-up after shunting for iNPH.
methodsFifty patients who fulfilled the diagnostic criteria for iNPH and who underwent shunt surgery with an adjustable Codman Certas Plus® valve without an antisiphoning device (ASD) were enrolled in this prospective single-center study. Clinical outcomes were assessed with the Hellstrom iNPH scale and Mini-Mental State Examination (MMSE) at baseline and at 3, 12, and 36 months. Ventricular volumes were measured via quantitative magnetic resonance imaging (qMRI) and automated segmentation. Overdrainage was defined clinically and/or radiologically.
resultsForty-two patients completed the 3-month follow-up, 86% of whom were classified as clinical responders. Gait improvement was sustained at 12 months, whereas cognitive gains were transient. The ventricular volume decreased significantly from baseline by a mean of 20% at 3 months (p < 0.001), with a further decreasing trend up to 36 months. The responders demonstrated greater relative ventricular reduction (21%) than the nonresponders did (10%) at 3 months, while ventricular reduction was equal at later timepoints. Overdrainage symptoms and events occurred in 12 out of 50 patients, including 7% with subdural collections. Patients with overdrainage symptoms showed markedly greater reductions in ventricular volume (35%) than asymptomatic patients did (16%; <0.001). Valve adjustments resulted in detectable volumetric changes, supporting volumetry as a noninvasive marker of shunt function.
conclusionVentricular volumetry is a sensitive tool for longitudinal follow-up after shunting in iNPH patients. A reduction of ventricular volume of approximately 20% is associated with clinical improvement, whereas a reduction exceeding 30% increases the risk of overdrainage symptoms. Routine baseline volumetry, early intensive follow-up and the routine use of ASDs could be used to optimize outcomes and minimize complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.